Navigation Links
Duke's Ralph Snyderman, M.D. Joins SenGenix as Senior Medical Advisor and Board Member
Date:11/12/2012

DURHAM, N.C., Nov. 12, 2012 /PRNewswire-iReach/ -- SenGenix, a private medical diagnostics company developing protein-based sensor technology for point-of-care testing, announced today that Ralph Snyderman, MD, Chancellor Emeritus of Duke University, has joined the company and will serve as senior medical advisor and a member of the Board of Directors.

Snyderman served as Chancellor for Health Affairs at Duke for 15 years and guided development of the Duke University Health System, one of the first fully integrated academic health systems in the United States.  He also served as its Chief Executive Officer.  Prior to Duke, Snyderman was Senior Vice President, medical research and development, for Genentech. He has earned numerous honors and awards during his career and has served as an advisor and board member for several companies.

"Dr. Snyderman's experience in clinical medicine, biotechnology research and industry is an exceptional asset for SenGenix in commercializing its protein engineering technologies for fast, highly accurate and low cost point-of care testing," said Lawrence Cohen, Chief Executive Officer of SenGenix.  "Dr. Snyderman's global reputation as a health system executive, clinician and researcher will help SenGenix build strong relationships with clinical investigators, physicians and hospital executives as we move forward in product development and into global market introduction."

Founded in 2012, SenGenix will commercialize protein engineering technologies to create a new platform for a menu of the most commonly ordered patient tests that can be performed in any environment -- emergency departments, operating rooms, out-patient surgical centers, physician offices, ambulances, and disaster sites.  SenGenix's technology, which was originally developed at Duke University Medical Center, uses fluorescently responsive sensors printed on test strips to provide easy, highly accurate results in seconds with just a drop of blood.  Unlike other point-of-care testing systems, no expensive sampling cartridges or reader instruments are required with SenGenix technology. 

More information about SenGenix is available at www.sengenix.com.

Media Contact: Lawrence Cohen SenGenix, Inc., 646-354-8361, lcohen@sengenix.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE SenGenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit
2. Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
3. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
4. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
5. David F. Harty Joins Systech International as Vice President
6. Jim DuCharme Joins Prime Therapeutics as Chief Financial Officer
7. Ted Pacha Joins Pinnaclife as President of its Healthcare Distribution Division
8. Rittal Corp. Joins the HP ProActive Insight Architecture Alliance
9. Anthony Creed Joins DDSTUDIO As GM, Experience Design
10. IntelliCell Announces Dr. Arnold I. Caplan Joins Scientific Advisory Board
11. American Society of Hematology joins European Hematology Association, Patient Groups in Issuing International Call to Action to Alleviate Drug Shortages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... TX (PRWEB) , ... June 24, 2016 , ... People ... part in Genome magazine’s Code Talker Award, an essay contest in which patients and ... an award to be presented at the 2016 National Society of Genetic Counselors (NSGC) ...
Breaking Medicine News(10 mins):